Cristin-resultat-ID: 1026438
Sist endret: 28. august 2013 10:19
NVI-rapporteringsår: 2013
Resultat
Vitenskapelig artikkel
2013

Margins and market shares: Pharmacy incentives for generic substitution

Bidragsytere:
  • Kurt Brekke
  • Tor Helge Holmås og
  • Odd Rune Straume

Tidsskrift

European Economic Review
ISSN 0014-2921
e-ISSN 1873-572X
NVI-nivå 2

Om resultatet

Vitenskapelig artikkel
Publiseringsår: 2013
Volum: 61
Sider: 116 - 131

Importkilder

Isi-ID: 000320479900008

Beskrivelse Beskrivelse

Tittel

Margins and market shares: Pharmacy incentives for generic substitution

Sammendrag

We study the impact of product margins on pharmacies’ incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies’ substitution incentives are determined by relative margins and relative patient copayments. Second, we exploit a unique product level panel data set, which contains information on sales and prices at both producer and retail level. In the empirical analysis, we find a strong relationship between the margins of brand- names and generics and their market shares. This relationship is stronger for pharma- ceuticals under reference pricing rather than coinsurance. In terms of policy implications, our results suggest that pharmacy incentives are crucial for promoting generic sales.

Bidragsytere

Kurt Richard Brekke

Bidragsyterens navn vises på dette resultatet som Kurt Brekke
  • Tilknyttet:
    Forfatter
    ved Institutt for samfunnsøkonomi ved Norges Handelshøyskole

Tor Helge Holmås

  • Tilknyttet:
    Forfatter
    ved NORCE Samfunn ved NORCE Norwegian Research Centre AS

Odd Rune Straume

  • Tilknyttet:
    Forfatter
    ved Institutt for økonomi ved Universitetet i Bergen
  • Tilknyttet:
    Forfatter
    ved Universidade do Minho
1 - 3 av 3